Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: January 7, 2025


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Grant


Match Required: No


Status: Posted


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

The Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases Grant, also referred to as R21, is a funding opportunity designed to encourage the creation of innovative tools and technologies. The specific focus of these advancements should be towards improving areas of kidney, urologic, and hematologic diseases. Notably, clinical trials are not permissible under this grant. The primary aim is to support development in these medical fields, with the ultimate aim of advancing medical treatments and potential cures.
Show More

Key Dates

Open Date: April 11, 2023


Application Due Date: January 7, 2025


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.